FDA Moves to Eliminate Oral Phenylephrine from OTC Nasal Decongestants

Review finds oral phenylephrine ineffective, leading to a proposal for market removal. The U.S. Food and Drug Administration (FDA) recently proposed removing oral phenylephrine from over-the-counter (OTC) products…

Read More

FDA Approves New Hemophilia Treatment Hympavzi

Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…

Read More

Hurricane Helene Recovery Efforts Continue, States of Emergency Extended

Tens of thousands are still without power in North Carolina and Georgia. In Georgia, the Department of Health and Human Services is putting prescription replacement programs in place…

Read More

Supreme Court Declines Appeal by Former Pharma Executive

The court upholds the $64 million penalty, holding the former CEO liable for price gouging and fraud. The Supreme Court declined to hear an appeal filed by former…

Read More

HHS Adds 54 Drugs to Medicaid Drug Rebate Program

Drugs will have a lowered coinsurance rate for 822,000 enrollees. The Department of Health and Human Services (HHS) announced that 54 drugs have been added to Medicaid’s Drug…

Read More

Medicare Announces Maximum Drug Prices After Negotiations

HHS secretary states that the negotiations will save Americans $3.7 billion in the first year. Medicare announced its first finalized list of drug price maximums for 10 prescription…

Read More

HHS Reports Lower Medicare Prices on 10 Drugs

The deal is expected to save billions for Medicare and reduce out-of-pocket costs for millions of seniors starting in 2026. The Department of Health and Human Services (HHS)…

Read More

HHS Updates Payment Policies for Medicare and Medicaid

Issues final rule for inpatient hospitals and long-term care hospitals. The Department of Health and Human Services (HHS) issued a final rule last week updating Medicare payment policies…

Read More

HHS Issues Final Guidance for Medicare Prescription Payment Plan

New initiative to ease out-of-pocket drug costs and cap annual expenses at $2,000 for Medicare beneficiaries by 2025. The Department of Health and Human Services (HHS), through the…

Read More

Legislators Raise Concerns About Inflated Rx Costs for Troops

Some members of Congress question the prescription monopoly under Pentagon’s Tricare. Bipartisan members of Congress have questioned the Pentagon about the exclusive prescription contract the Defense Health Agency…

Read More

Back to top
FE3